These results suggest a possible improvement with DEB compared with conventional TACE, which shows a mean CR of 6%. Thus although TAE is similar to TACE, it cannot be considered a definitive ...

Transarterial chemoembolization (TACE) improves survival in cirrhotic patients with hepatocellular carcinoma (HCC). The optimal schedule, best anticancer agent and best technique are still unclear.